← Browse by Condition
Medical Condition
systemic sclerosis ssc
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1
ClinicalMetric tracks all active clinical trials for systemic sclerosis ssc sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — systemic sclerosis ssc Clinical Trials
How many clinical trials are currently recruiting for systemic sclerosis ssc?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for systemic sclerosis ssc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for systemic sclerosis ssc?
systemic sclerosis ssc research spans Phase 1 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a systemic sclerosis ssc clinical trial?
Eligibility criteria for systemic sclerosis ssc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07182981
Recruiting
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Hacettepe University
NCT07167537 Phase 1
Recruiting
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
Enrollment
44 pts
Location
China
Sponsor
Beijing GoBroad Hospital
NCT07402226
Recruiting
Systemic Sclerosis DIet for GastrointESTinal Symptoms
Enrollment
60 pts
Location
United States
Sponsor
University of Michigan
NCT06598982
Recruiting
Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis
Enrollment
85 pts
Location
Turkey (Türkiye)
Sponsor
Selcuk University
NCT06792344 Phase 1
Recruiting
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
Enrollment
12 pts
Location
China, Christmas Isl...
Sponsor
The Children's Hospital of Zhe...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology